T-cell Lymphoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
Conditions:   NK/T Cell Lymphoma;   Vascular Immunomother T Cell Lymphoma;   Non-Hodgkin Lymphoma Intervention:   Drug: GNC-038 Sponsors:   Sichuan Baili Pharmaceutical Co., Ltd.;   SystImmune Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2022 Category: Research Source Type: clinical trials